Endoscopic Retrograde Cholangiopancreatography Market Research Report Information By Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting and Others), By End User (Hospitals & Clinics and Ambulatory Surgical Centers), By Application (Bile Duct, Pancreas and Others), By Product (Endoscopes (Endotherapy Devices, Catheters, Stents, Balloons, Guiding Wires, Others), Imaging Devices and Energy Devices), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 20

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Application

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT

6.1. Overview

6.2. Endoscopes

6.3. Endotherapy Devices

6.3.1. Catheters

6.3.2. Stents

6.3.3. Balloons

6.3.4. Guiding Wires

6.3.5. Others

6.4. Imaging Devices

6.5. Energy Devices

7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PROCEDURE

7.1. Overview

7.2. Biliary Sphincterotomy

7.3. Biliary Stenting

7.4. Biliary Dilatation

7.5. Pancreatic Duct Stenting

7.6. Others

8. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION

8.1. Overview

8.2. Bile Duct

8.3. Pancreas

8.4. Others

9. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER

9.1. Overview

9.2. Hospitals & Clinics

9.3. Ambulatory Surgical Centers

9.4. Others

10. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY REGION

10.1. Overview

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. France

10.2.3. UK

10.2.4. Italy

10.2.5. Spain

10.2.6. Rest of Europe

10.3. Asia-Pacific

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Australia

10.3.6. Rest of Asia-Pacific

10.4. Rest of the World

10.4.1. Middle East

10.4.2. Africa

10.4.3. Latin America

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Endoscopic Retrograde Cholangiopancreatography Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Endoscopic Retrograde Cholangiopancreatography Market

11.7. Key developments and Growth Strategies

11.7.1. New Product Launch

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales & Operating Income, 2021

11.8.2. Major Players R&D Expenditure. 2021

12. COMPANY PROFILES

12.1. Olympus Corporation

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Products Offered

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Fujifilm Holdings Corproation

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Products Offered

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. STERIS PLC

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Products Offered

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Cook Medical

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Products Offered

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Boston Scientific Corporation

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Products Offered

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. CONMED Corporation

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Products Offered

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. HOYA Group

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Products Offered

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Q3 Medical Devices Limited

12.8.1. Company Overview

12.8.2. Financial Overview

12.8.3. Products Offered

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Ambu Inc.

12.9.1. Company Overview

12.9.2. Financial Overview

12.9.3. Products Offered

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Medtronic Plc

12.10.1. Company Overview

12.10.2. Financial Overview

12.10.3. Products Offered

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Others

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SYNOPSIS, 2018–2030

TABLE 2 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET ESTIMATES & FORECAST, 2018–2030 (USD MILLION)

TABLE 3 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 4 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 5 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 6 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 7 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 8 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 9 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 10 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 11 US: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 12 US: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 13 US: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 14 US: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 15 CANADA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 16 CANADA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 17 CANADA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 18 CANADA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 1 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 2 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 3 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 4 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 5 GERMANY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 6 GERMANY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 7 GERMANY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 8 GERMANY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 9 FRANCE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 10 FRANCE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 11 FRANCE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 12 FRANCE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 13 ITALY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 14 ITALY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 15 ITALY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 16 ITALY: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 17 SPAIN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 18 SPAIN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 19 SPAIN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 20 SPAIN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 21 UK: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 22 UK: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 23 UK: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 24 UK: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 25 REST OF EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 26 REST OF EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 27 REST OF EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 28 REST OF EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 29 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 30 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 31 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 32 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 33 JAPAN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 34 JAPAN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 35 JAPAN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 36 JAPAN: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 37 CHINA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 38 CHINA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 39 CHINA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 40 CHINA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 41 INDIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 42 INDIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 43 INDIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 44 INDIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 45 AUSTRALIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 46 AUSTRALIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 47 AUSTRALIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 48 AUSTRALIA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 49 SOUTH KOREA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 50 SOUTH KOREA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 51 SOUTH KOREA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 52 SOUTH KOREA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 53 REST OF ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 54 REST OF ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 55 REST OF ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 56 REST OF ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 57 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 58 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 59 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 60 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 61 MIDDLE EAST: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 62 MIDDLE EAST: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 63 MIDDLE EAST: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 64 MIDDLE EAST: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 65 AFRICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 66 AFRICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 67 AFRICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 68 AFRICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

TABLE 69 LATIN AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, 2018–2030 (USD MILLION)

TABLE 70 LATIN AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, 2018–2030 (USD MILLION)

TABLE 71 LATIN AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 72 LATIN AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END USER, 2018–2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET

FIGURE 4 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY PRODUCT, 2021

FIGURE 5 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY PROCEDURE, 2021

FIGURE 6 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY APPLICATION, 2021

FIGURE 7 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY END USER, 2021

FIGURE 8 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY REGION, 2021

FIGURE 9 NORTH AMERICA: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 10 EUROPE: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 11 ASIA-PACIFIC: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 12 REST OF THE WORLD: GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE (%), BY REGION, 2021

FIGURE 13 GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: COMPANY SHARE ANALYSIS (%), 2021

FIGURE 14 OLYMPUS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 OLYMPUS CORPORATION: SWOT ANALYSIS

FIGURE 16 FUJIFILM HOLDINGS CORPROATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 FUJIFILM HOLDINGS CORPROATION: SWOT ANALYSIS

FIGURE 18 STERIS PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 STERIS PLC: SWOT ANALYSIS

FIGURE 20 COOK MEDICAL: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 COOK MEDICAL: SWOT ANALYSIS

FIGURE 22 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS

FIGURE 24 CONMED CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 CONMED CORPORATION: SWOT ANALYSIS

FIGURE 26 HOYA GROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 HOYA GROUP: SWOT ANALYSIS

FIGURE 28 Q3 MEDICAL DEVICES LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 Q3 MEDICAL DEVICES LIMITED: SWOT ANALYSIS

FIGURE 30 AMBU INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 AMBU INC.: SWOT ANALYSIS

FIGURE 32 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 MEDTRONIC PLC: SWOT ANALYSIS